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Abstract: Background Previous research has demonstrated that the neuropeptide oxytocin modulates
social behaviors and reduces anxiety. However, effects of oxytocin on startle reactivity, a well-validated
measure of defense system activation related to fear and anxiety, have been inconsistent. Here we inves-
tigated the influence of oxytocin on startle reactivity with particular focus on the role of trait anxiety.
Methods Forty-four healthy male participants attended two experimental sessions. They received in-
tranasal oxytocin (24 IU) in one session and placebo in the other. Startle probes were presented in
combination with pictures of social and non-social content. Eye-blink startle magnitude was measured
by electromyography over the musculus orbicularis oculi in response to 95 dB noise bursts. Participants
were assigned to groups of high vs. low trait anxiety based on their scores on the trait form of the
Spielberger State-Trait Anxiety Inventory (STAI). Results A significant interaction effect of oxytocin
with STAI confirmed that trait anxiety moderated the effect of oxytocin on startle reactivity. Post-hoc
tests indicated that for participants with elevated trait anxiety, oxytocin increased startle magnitude,
particularly when watching non-social pictures, while this was not the case for participants with low
trait anxiety. Conclusion Results indicate that effects of oxytocin on defense system activation depend
on individual differences in trait anxiety. Trait anxiety may be an important moderator variable that
should be considered in human studies on oxytocin effects.
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Previous research has demonstrated that the neuropeptide oxytocin modulates social
behaviors and reduces anxiety. However, effects of oxytocin on startle reactivity, a well-vali-
dated measure of defense system activation related to fear and anxiety, have been inconsis-
tent. Here we investigated the influence of oxytocin on startle reactivity with particular focus
on the role of trait anxiety.
Methods
Forty-four healthy male participants attended two experimental sessions. They received
intranasal oxytocin (24 IU) in one session and placebo in the other. Startle probes were pre-
sented in combination with pictures of social and non-social content. Eye-blink startle mag-
nitude was measured by electromyography over the musculus orbicularis oculi in response
to 95 dB noise bursts. Participants were assigned to groups of high vs. low trait anxiety
based on their scores on the trait form of the Spielberger State-Trait Anxiety Inventory
(STAI).
Results
A significant interaction effect of oxytocin with STAI confirmed that trait anxiety moderated
the effect of oxytocin on startle reactivity. Post-hoc tests indicated that for participants with
elevated trait anxiety, oxytocin increased startle magnitude, particularly when watching non-
social pictures, while this was not the case for participants with low trait anxiety.
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Conclusion
Results indicate that effects of oxytocin on defense system activation depend on individual
differences in trait anxiety. Trait anxiety may be an important moderator variable that should
be considered in human studies on oxytocin effects.
Introduction
The effect of the neuropeptide oxytocin on social behavior, anxiety, and stress reactivity has
received increased attention in the last decade [1, 2]. Oxytocin may play a key role in the recog-
nition of emotional facial expressions [3–6] and in related memory [7], interpersonal trust and
cooperation [8], and attachment [9] in humans. Oxytocin also reduces behavioral and endo-
crine responses to social stress and mediates stress-protective effects of social support [10].
Moreover, recent studies suggest that the effect of oxytocin is dependent on social context
[11]. Oxytocin might enhance the early and rapid conceptual detection of affect from social sti-
muli and might improve the accurate appraisal of affect from socially relevant information
[12]. Animal and human research has begun to investigate the effects of oxytocin on the startle
response, an important measure of defense system activation related to fear and anxiety [13].
The startle response is conceptualized as an involuntary reaction to an unexpected sudden
intense stimulus that contracts several muscles in order to protect the body from harm [14].
Startle reactivity can be measured using the eye-blink reflex, which is part of the whole-body
startle reaction and can easily be elicited by loud acoustic stimuli [15]. High startle reactivity is
characterized by high eye-blink amplitudes. The startle response is highly context-dependent
and can be modulated by many factors. In fear-potentiated startle, the startle response has sig-
nificantly greater amplitude because the aversive motivational system, including the amygdala,
is activated by a fear state [13, 16–18]. Thus, the startle response is a reliable index for fear in
animal and human fear conditioning [19] and a valuable indicator for the analysis of neural
systems associated with emotional activation, especially fear and anxiety, and emotion regula-
tion [16].
The investigation of the effects of oxytocin on the startle response has led to contradictory
results. Results of animal studies include increased startle response after oxytocin administra-
tion [20], no effects of oxytocin [21, 22], and reduced startle response after oxytocin adminis-
tration [23]. In humans, a recent placebo-controlled double-blind study showed that the eye-
blink startle magnitude was significantly larger in the oxytocin group than in the placebo
group during the viewing of negative, but not neutral or positive pictures [24]. On the other
hand, another study reported oxytocin to attenuate the startle reflex during the viewing of
both emotional and neutral pictures, irrespective of picture valence [25]. Unfortunately, these
two studies did not investigate social vs. non-social content of pictures, which might be an
additional important factor as social context may be particularly prone to influence oxytocin
effects [1].
Endogenous oxytocin has been shown to reduce anxiety and stress in the presence of fear-
evoking stimuli [26, 27]. Therefore, it appears justified to assume that the application of exoge-
nous oxytocin might lower levels of anxiety specifically in high trait anxious individuals. Con-
sistent with this assumption, a recent study evaluating responses to speech stress showed that
oxytocin reduced negative cognitive self-appraisals only in high trait anxious individuals [28].
On the other hand, and not consistent with this assumption, a recent animal study found that
oxytocin reduced startle responses in the context of a fear experiment only in rats with overall
Trait anxiety and oxytocin on startle
PLOS ONE | https://doi.org/10.1371/journal.pone.0190809 January 4, 2018 2 / 11
researchers.uzh.ch/static/fnf/stiftungen/stiftung.
php?id=4, recipient: CMS). The funders had no role
in study design, data collection and analysis,
decision to publish, or preparation of the
manuscript.
Competing interests: The authors have declared
that no competing interests exist.
low pre-fear startle responding[29], which may be considered a measure of trait anxiety in ani-
mals. In sum, the evidence on oxytocin affecting startle responding is quite inconclusive while
trait anxiety appears to be an important moderator.
The aim of the present study was to shed more light on these initial and somewhat contra-
dictory findings and investigate the relevance of individual differences in trait anxiety for influ-
encing the effects of oxytocin on human defense system activation. We thus investigated the
startle response during picture viewing, with a specific focus on the differences between social
and non-social content of pictures. We tentatively expected to find an oxytocin-related reduc-
tion of startle responses particularly in high trait anxious participants. Based on the impor-
tance of oxytocin particularly in the context of social stimuli, we expected such an effect to be
most pronounced with social compared to non-social stimuli.
Methods
Participants
Forty-four healthy non-smoking men were recruited through advertisements on pinboards
and homepages. Exclusion criteria were neurological or psychiatric disorders, liver, kidney or
heart diseases, allergy to preserving agents, use of medication including hormonal and herbal
medication during the 4 weeks preceding the study, participation in other clinical trials during
the 4 weeks preceding or during the study, impaired hearing (threshold over 30 dB), impaired
cognitive abilities (IQ known to be below 70) and insufficient command of German. Physical
and mental health was assessed by a structured screening interview (short medical history
assessment) and by the German version [30] of the Mini-International Neuropsychiatric Inter-
view (M.I.N.I.), a reliable and valid diagnostic structured interview [31, 32]. For sample infor-
mation on age and trait anxiety, see Table 1. Participants were instructed not to consume
alcohol or caffeine and not to exercise 24 hours before each session, and not to eat or drink
anything besides water two hours prior to the assessments. Seven participants took part in
only one of two sessions (see Table 1). Participants were thoroughly informed about the proce-
dures and gave written informed consent according to the Declaration of Helsinki before par-
ticipating. This study was approved by the local ethics committee and by the Swiss Regulatory
Institute for drug trials (Swissmedic) and is registered as clinical trial at ClinicalTrials.gov, trial
number NCT01066299. Monitoring of the study was performed by the Clinical Trial Center at
the University Hospital Zurich.
Table 1. Sample description.
N Range Mean SD Median
Both sessions 37
Placebo session only 4
Oxytocin session only 3
Age in years 44 18–51 27.2 8.6
STAI trait scores 44 23–56 33.6 6.2 32.5
Low trait anxiety High trait anxiety
N Range Mean SD N Range Mean SD p
Age in years 22 19–43 26.5 7.9 22 18–51 28.1 9.8 0.6
STAI trait scores 22 23–32 29.0 2.4 22 33–56 37.6 5.1 <0.001
STAI = State-Trait Anxiety Inventory
https://doi.org/10.1371/journal.pone.0190809.t001
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Procedure
The study took place at the psychophysiology laboratory at the Department of Psychiatry and
Psychotherapy, University Hospital Zurich, Switzerland. We used a double-blind placebo con-
trolled crossover design. Assessments were made on three visits. During the first visit partici-
pants were screened for inclusion and exclusion criteria and received a URL website link to fill
in the German version of the trait form of the Spielberger State-Trait Anxiety Inventory [33]
(STAI) online. Psychophysiological assessments took place during the second and third visits,
which were separated by one to four weeks (M = 14.1 days, SD = 6.9 days). One week after the
last visit participants were called for a follow-up check of their health status. Psychophysiologi-
cal assessments took place at 2:00 p.m. in order to account for diurnal variation of oxytocin
[10] and were structured as follows: How to use sprays was introduced to the participants
before use. We used a written instruction, including a posture (light bow position), a depth of
insertion (ca.1cm). Priming the sprays was conducted by the experimenters and confirmed its
function before use. The experimenters did not observe any leakage. The experimenters
observed the participants carefully. In addition, the study was conducted under the monitoring
of the Center for Clinical Trial at the University Hospital. Therefore the standardized adminis-
tration of the drug was performed under the strict supervision of our monitor.
First, 24 IU of an intranasal spray was administered (three puffs of four IU per nostril). Either
oxytocin (Syntocinon, Novartis, Basel, Switzerland) or placebo (containing all ingredients except
for the neuropeptide) was given at the first session and the other at the second session. The order
was randomized across participants. After administration of the spray participants were left
alone to read magazines for about 20 minutes. Then, sensors were attached while participants sat
in a comfortable chair and they were subsequently asked to rest quietly for seven minutes in
order to facilitate adaptation to the laboratory setting. Forty-five minutes after spray application,
participants were given headphones and told that the session would start.
A background noise of 70dB was running throughout the session to mask any environmen-
tal sounds. Startle probes were presented as bursts of white noise (95 dB, 40 ms duration, sud-
den onset). Thirty-eight pictures from the International Affective Picture System (IAPS) [34]
were shown for six seconds each with inter-trial intervals of 15–20 s (M = 17 s). The first two
trials were not included in the analysis. These two habituation trials each consisted of a neutral
picture and a startle probe. During the presentation of 24 of the remaining 36 pictures a startle
probe was given 3.5 s, 4.0 s or 4.5 s after picture onset. Time points for the startle probes were
varied to make them less predictable. Another six startle probes were given between pictures
and 12 pictures were shown without a startle probe. The half of the pictures was of social
(showing people) and the other half of non-social content. Participants were assigned to one of
the two possible orders of set A and B, using the research randomizer (www.randomizer.org).
We selected pictures with mild arousal scores between 3 and 5 from IAPS, because we planned
to focus on the difference between social and non-social picture contents, not to focus on the
affective stimulus. Each set consisted of 12 neutral, 12 positive and 12 negative pictures. A
description of the picture sets is presented in Table 2. Task presentation was done via E-Prime
2.0 Professional (Psychology Software Tools Inc., Pittsburgh, PA., USA). Pictures were shown
on a 19” computer screen and acoustic stimuli were presented binaurally via a Sony
STR-DE197 amplifier and Novitronic sealed headphones. Noise volume level was calibrated
using a Voltcraft SL-100 sound-level measuring device.
We have no severe adverse events throughout our study, but there were eight cases
with mild adverse events (e.g. exhausted, cold, nose bleeding); three were placebo and 5 were
oxytocin. There were no differences in the adverse events reported between the two sprays
(p = 0.48).
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Physiological measurement and data reduction
Recording of the physiological signals was performed using a BIOPAC MP150 system
(Biopac Systems, Inc, Goleta, CA). Facial electromyographic (EMG) activity from the left
musculus orbicularis oculi was recorded using Ag/AgCl electrodes filled with electrolyte
gel. EMG was sampled at a 1000Hz rate. Autonomic Nervous System Laboratory 2.51
(ANSLAB; Wilhelm, F. H. & Peyk, P., 2005; available at the SPR Software Repository:
http://www.sprweb.org) was used to filter raw data and extract startle responses. The star-
tle EMG was 50Hz notch filtered, rectified and startle eye-blink magnitude (baseline cor-
rected peak amplitude for response trials) was computed. The 50ms before the startle
probe onset were used as baseline. The 100ms startle response window started 20ms after
probe onset. Due to insufficient data quality, 3.3% of trials had to be excluded from analy-
sis. To reduce inter-individual variance all startle eye-blink magnitudes were t-trans-
formed within subjects and t-scores are reported.
Table 2. Description of the two picture sets.
Set A Social
IAPS no. Description IAPS no. Description IAPS no. Description
2435 Mother & son 2091 Kids with kittens 2110 AngryFace
2487 Musician 2154 Father & son 2750 Bum
2579 Bakers 2311 Mother with daughter 2799 Funeral
3550.2 Coach 2360 Family 6311 Distressed woman
7496 People in street 2530 Couple 9220 Couple at cemetery
9171 Fisher 5831 Father & child at beach 9342 Men in polluted area
Set A Non-social
IAPS no. Description IAPS no. Description IAPS no. Description
5395 Ship 5200 Flowers 9000 Cemetery
5532 Mushrooms 5551 Clouds 9090 Exhaust
7037 Trains 5611 Mountains 9301 Toilet
7042 Barbells 5780 River 9373 Garbage
7095 Headlight 5814 Palm beach 9470 Destroyed house
7211 Clock 5910 Fireworks 9830 Cigarette stubs
Set B Social
IAPS no. Description IAPS no. Description IAPS no. Description
2305 Woman 2332 Infant with puppy 2053 Premature infant
2394 Medical worker 2339 Soccer player & kids 2141 Grieving woman
2515 Harvest 2373 Mariachi band 2399 Woman with headache
2593 Men in restaurant 2550 Old couple 3301 Injured child
2595 Women 5836 Couple at beach 9415 Handicapped
2635 Cowboy 8497 Roller coaster ride 9584 Dental exam
Set B Non-social
IAPS no. Description IAPS no. Description IAPS no. Description
7484 Grilled fish 5300 Galaxy 9320 Vomit
7560 Freeway 5594 Sky 9471 Burnt building
7920 Mud 5600 Mountains 9101 Cocaine
7242 Building 5631 Mountains 9290 Garbage
7058 Dice 5779 Courtyard 9340 Garbage
7057 Coffee cup 7545 Ocean view 9280 Smoke
https://doi.org/10.1371/journal.pone.0190809.t002
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Data analysis
Statistical analyses were performed using IBM SPSS Statistics 23 (SPSS Inc., Chicago, Ill,
USA). We used a linear mixed model design to compare conditions. Trait anxiety (STAI trait
scores) was used as a covariate. The model for eye-blink magnitude during picture viewing
contained Substance (oxytocin or placebo), Picture Content (social or non-social), STAI trait,
as well as all possible interactions as fixed effects. After this analysis, to visualize and to decom-
pose the significant interaction effects, STAI trait scores were median split and build two
groups of participants with low vs. high trait anxiety scores (see Table 1). Bonferroni corrected
pairwise comparisons based on the estimated marginal means were used as post-hoc tests.
Results
There were no main effects of Substance (p = 0.769), Picture Content (p = 0.445), or STAI trait
(p = 0.992). There was a significant interaction effect of Substance x STAI trait (F (1, 194) =
6.25, p = 0.013), and there was a trend interaction effect of Substance x Picture Content (F (1,
1667) = 29.4, p = 0.086); the significant Substance x STAI trait interaction effect was further
qualified by a significant threefold interaction effect of Substance x Picture Content x STAI
trait (F (1, 1700) = 6.13, p = 0.013). The analysis using STAI trait Groups instead of STAI trait
scores yielded the same non-significant main effects and the same significant interaction
effects. Decomposition of these interaction effects showed that significant differences were
observed between oxytocin and placebo in individuals with higher STAI trait scores when
watching nonsocial pictures (Mdiff = 3.81, SEdiff = 1.07, 95% CI: 1.70 to 5.91, P< 0.001);
between higher and lower STAI trait Group in nonsocial pictures with oxytocin (Mdiff = 3.02,
SEdiff = 1.09, 95% CI: 0.88 to 5.16, P = 0.006) and with placebo (Mdiff = 2.63, SEdiff = 1.08, 95%
CI: 0.51 to 4.75, p = 0.015); and between social and non-social pictures in higher STAI trait
Group with oxytocin (Mdiff = 2.34, SEdiff = 0.90, 95% CI: 0.59 to 4.10, P = 0.009) (Fig 1).
Discussion
The main aim of this study was to investigate the influence of oxytocin on the startle reflex and
how trait anxiety modulates this relationship. As expected, our results point to a modulatory
role of trait anxiety on oxytocin effects on eye-blink startle during picture viewing. Specifically,
participants with higher STAI trait scores showed stronger startle responses under oxytocin
than under placebo when viewing pictures of non-social content. The startle reflex is a measure
of defense system activation and defensive motivation [17]. Our results therefore suggest that
for individuals with higher trait anxiety oxytocin increases defensive responding in a non-
social context. These results complement those found by Striepens et al. (2012)[24] in contra-
dicting an unspecific anxiety reducing effect of oxytocin. The differential effects of oxytocin on
the startle reflex specific to high trait anxiety suggest that there are relevant interactions
between individual trait characteristics and oxytocin. Anxiety reducing effects of oxytocin
might be specific to certain personality traits in individuals under specific social-affective con-
text conditions. However, the direction of the influence of trait anxiety was contrary to what
we had expected. As Alvares et al. (2012) [28] had found stress-reducing effects of oxytocin in
high trait-anxious individuals, we expected a startle-reducing effect of oxytocin in high trait-
anxious participants. However, our data demonstrated stronger startle responses under oxyto-
cin compared to placebo for high trait anxiety. A recent study found anxiety-enhancing effects
of oxytocin in response to unpredictable threat [35]. In our study, startle-probe bursts were
not cued and occurred at different time points within the picture presentation. Unpredictabil-
ity might therefore in part explain the discrepancy between our results and those of Alvares
et al. (2012) [28], where the stressor was continuous and therefore predictable.
Trait anxiety and oxytocin on startle
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One caveat of our results is the finding of contradictory results on the effect of oxytocin in
social contexts. While a large empirical evidence supports a specific role of oxytocin on social
settings, what gave rise to several socially-oriented accounts of oxytocin’s effects [36, 37] (for
instance the prosocial theory or the social salience hypothesis of oxytocin), our results indicate
an enhanced effect of oxytocin on the startle reflex in association with the presentation of the
non-social pictures. This might be partly explained by the choice of our non-social stimuli.
Contrary to previous studies (for instance, Striepens et al., 2012), we used non-social pictures
from different contexts, while these authors chose their non-social pictures from one specific
context (household and kitchen). It is therefore possible that this context variability influenced
our results. In addition, we presented social and non-social stimuli for all three valence condi-
tions (neutral, positive and negative), while previous studies on the effect of oxytocin on startle
used only neutral non-social pictures. Finally, very few studies investigated the effect of oxyto-
cin on the modulation of startle, and the research supporting the prosocial effects of oxytocin
use different types of social stimulation (only pictures, or faces for instance). Our results indi-
cate therefore that the choice of the social and non-social stimuli might influence the observed
Fig 1. Estimated marginal means +/- 1 standard error for eye-blink magnitude (t-scores). Substance (placebo, oxytocin) x Picture Content (social, non-
social) x STAI Group (low trait anxiety, high trait anxiety) Interaction effect, F (1, 1700) = 6.13, p = 0.013. *p<0.05, ** p < 0.01, *** p < 0.001.
https://doi.org/10.1371/journal.pone.0190809.g001
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effects of oxytocin. This is also in line with the current reflections on the replicability of the
social and behavioral effects of oxytocin.
There are several limitations to this study. First, since the level of high trait anxiety in our
healthy male sample was still within a subclinical range, our results cannot necessarily be gen-
eralized to individuals with mental disorders associated with severe anxiety. Second, it also
should be kept in mind that static pictures with social content are only a relatively mild social
stimulus. More naturalistic social stimuli [38] might have produced different results. Third, we
only investigated men in order to exclude endocrine influences of the female menstrual cycle.
It is a major limitation that sex differences could not be tested in the current study. Fourth,
several factors including anatomy of the nose and airways, nasal cavity environment, the nasal
spray formulation, the bottle design, using standardized instructions across experiments [39],
or pharmacokinetics and dose-dependncy on human brain reactivity [40] could influence the
variability of response to oxytocin nasal spray. Fifth, it is not possible in our study to control
for the effect of probe latency, and of the variation of interstimulus intervals on startle, because
we did not keep data about randomization of the probe latency.
In conclusion, our results show that oxytocin affects the human defense system activation
in complex ways. As the effect of oxytocin on the startle response depended on trait anxiety,
future studies may benefit from taking this important individual-difference variable into
account. A neglect of trait anxiety in most oxytocin studies on startle reactivity may be partially
responsible for previous contradictory results. Further studies in clinical populations are
needed to understand these effects in the framework of anxiety and stress related disorders
and their relationship to oxytocin interventions for these conditions.
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